LAS VEGAS – CovInnovationsTM, a Las Vegas-based biotech company, is announcing a strategic partnership with Roseman University of Health Sciences for research on COVID-related therapies and treatments, particularly a new medical advance that has shown significant increase in survival rates for late-stage COVID-19 patients requiring hospitalization and oxygen or who have been … [Read more...] about Covinnovations Announces Partnership with Roseman University for COVID-19 Treatment and Therapy Research — Preliminary data for new late-stage treatment shows at least 93.5 percent survival rate for patients who are oxygen dependent or intubated —
CovinnovationsTM
Covinnovations to Present to Investors at 2022 Biotech Showcase — Company Will Highlight New COVID-19 Treatment for Patients with Severe Symptoms Who Are Oxygen Dependent or Intubated
LAS VEGAS – CovinnovationsTM has been invited to participate in the 2022 Biotech Showcase, an investor conference for innovators in medical, life sciences and other biotechnology industries, January 10-12, 2022. Covinnovations will highlight a revolutionary new treatment, CovArrestTM, for hospitalized patients with severe COVID-19 symptoms. An earlier version of the drug … [Read more...] about Covinnovations to Present to Investors at 2022 Biotech Showcase — Company Will Highlight New COVID-19 Treatment for Patients with Severe Symptoms Who Are Oxygen Dependent or Intubated